Loading clinical trials...
Loading clinical trials...
Cohorte ANRS CO5 "Cohorte Nationale VIH2"
The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.
The secondary objectives are : * Describe the epidemiological and clinical characteristics of participants infected with HIV-2, and the immuno-virological characteristics of the infection. * To study the clinical and immunological progression of HIV-2 infection and the prognostic factors of this evolution. * Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection. * Allow an evaluation of the care practices of participants followed in French hospitals * Provide a bank of clinical-biological data and samples allowing the performance of virological and / or immunological studies on HIV-2 infection. The follow-up of the participants is different according to the therapeutic status of the participants, naive of antiretroviral treatment or already treated with antiretrovirals.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre hospitalier Victor Dupouy
Argenteuil, France
Avicenne
Bobigny, France
Hôpital Saint André
Bordeaux, France
Service de Medecine Interne Hopital Antoine Beclere
Clamart, France
Hôpital Louis Mourier
Colombes, France
Hôpital Sud Francilien
Corbeil-Essonnes, France
Hôpital Henri Mondor
Créteil, France
Service de Médecine interne - Centre Hospitalier Intercommunal
Créteil, France
Hôpital Edouard Herriot
Lyon, France
Hôpital de La Croix Rousse
Lyon, France
Start Date
January 1, 1994
Primary Completion Date
September 30, 2022
Completion Date
September 30, 2022
Last Updated
December 8, 2020
1,185
ESTIMATED participants
Antiretroviral
DRUG
Lead Sponsor
ANRS, Emerging Infectious Diseases
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions